Neuropsychopharmacology (BMRI5013)


This elective unit will focus on neuropsychopharmacology as a tool for characterizing brain pathways and as a treatment for brain disorders. Students will be introduced to basic principles of pharmacology governing drug binding and metabolism that underlie the rationale for drug design. Links between brain circuitry and phenomenology of mood disorders, psychosis and addictions will be examined to provide a rationale for chosen drug targets. Students will also examine the relationship between dosage, specificity and negative side effects of such drugs and how to evaluate costs and benefits of drug treatment in model scenarios. There will be the opportunity to examine current directions in neuropharmacology research, the role of the pharmaceutical industry and potential new pathways for future drug design.

Our courses that offer this unit of study

Further unit of study information


one day workshop in weeks 2, 7 and 10


Online test (25%), short answer test (25%), Oral and Writtent Presentation (50%)


Stahl, S. M. (2013). Stahl's essential psychopharmacology: neuroscientific basis and practical applications. 4th Edition, Cambridge university press.

Faculty/department permission required?


Study this unit outside a degree

Non-award/non-degree study

If you wish to undertake one or more units of study (subjects) for your own interest but not towards a degree, you may enrol in single units as a non-award student.

Cross-institutional study

If you are from another Australian tertiary institution you may be permitted to underake cross-institutional study in one or more units of study at the University of Sydney.